By Elsas M.I.C.G.   Vargaftig B.B.   Elsas P.X.   in Trends in Pharmacological Sciences

ISSN:0165-6147|21|11|417-420

Elsevier‎(2000)‎

Access to resources Favorite 10.625397

By Bureau M.F.   De Castro C.M.B.   Cortese C.   Bachelet M.   Vargaftig B.B.   in European Journal of Pharmacology

ISSN:0014-2999|324|1|89-98

Elsevier‎(1997)‎

Access to resources Favorite 10.179954

By Lapa e Silva J.R.   Possebon da Silva M.D.   Lefort J.   Vargaftig B.B.   in Toxicology

ISSN:0300-483X|152|1|31-35

Elsevier‎(2000)‎

Access to resources Favorite 10.179954

By De Castro C.M.M.B.   Nahori M.-A.   Dumarey C.H.   Vargaftig B.B.   Bachelet M.   in European Journal of Pharmacology

ISSN:0014-2999|294|2|669-676

Elsevier‎(1995)‎

Access to resources Favorite 9.73451

By Garrelds I.M.   De Graaf-in 't Veld T.   Nahori M.-A.   Vargaftig B.B.   van Wijk R.G.   Zijlstra F.J.   in European Journal of Pharmacology

ISSN:0014-2999|275|3|295-300

Elsevier‎(1995)‎

Access to resources Favorite 8.851779

Prostaglandins-Immunopharmacology‎

By Vargaftig   B. B.  

ISBN:9781483156354

Elsevier Science‎(2013)‎

Access to resources Favorite 7.061851

By Lapa J. R.   Silva E.   Ruffie C.   Lefort J.   Nahori M-A.   Vargaftig B. B.   Pretolani M.   in Mediators of Inflammation

ISSN:1466-1861|8|1|17-23

Informa Healthcare‎(1999)‎

Access to resources Favorite 3.5309255

By Faccioli L. H.   Medeiros A. I.   Malheiro A.   Pietro R. C. L. R.   Januario A.   Vargaftig B. B.   in Mediators of Inflammation

ISSN:1466-1861|7|1|41-47

Informa Healthcare‎(1998)‎

Access to resources Favorite 3.0895598